Journal of Clinical and Aesthetic Dermatology

Ingenol Mebutate Topical Gel 2016

An evidence-based, peer-reviewed journal for practicing clinicians in the field of dermatology

Issue link: http://jcadonline.epubxp.com/i/754617

Contents of this Issue

Navigation

Page 1 of 11

JOURNAL OF CLINICAL AND AESTHE TIC DERMATOLOGY EDITORIAL CORRESPONDENCE should be directed to: Kimberly B. Chesky, Vice President/Executive Editor, JCAD Matrix Medical Communications 1595 Paoli Pike, Suite 201 West Chester, PA 19380 Toll-free: (866) 325-9907; Phone: (484) 266-0702 Fax: (484) 266-0726. Website: www.jcadonline.com. E-mail: kchesky@matrixmedcom.com ADVERTISING QUERIES should be addressed to: Joseph J. Morris, Vice President/Publisher, JCAD Matrix Medical Communications 1595 Paoli Pike, Suite 201 West Chester, PA 19380 Toll-free: (866) 325-9907; Phone:E(484) 266-0702 Fax: (484) 266-0726. E-mail:jmorris@matrixmedcom.com. Copyright © 2016 Matrix Medical Communications. All rights reserved. Opinions expressed by authors, contributors, and advertisers are their own and not necessarily those of Matrix Medical Communications, the editorial staff, or any member of the editorial advisory board. Matrix Medical Communications is not responsible for accuracy of dosages given in the articles printed herein. The appearance of advertisements in this journal is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality, or safety. Matrix Medical Communications disclaims responsibility for any injury to persons or property resulting from any ideas or products referred to in the articles or advertisements. For reprint information and pricing, contact Matrix Medical Communications. The Journal of Clinical and Aesthetic Dermatology (ISSN 1941-2789) is published 12 times yearly by Matrix Med- ical Communications. The journal is printed by Publish- ers Press, Shepherdsville, Kentucky. Printed in the United States of America on acid-free paper. www.jcadonline.com JOURNAL STAFF EDITOR-IN-CHIEF, CLINICAL DERMATOLOGY James Q. Del Rosso, DO, FAOCD Lakes Dermatology and Del Rosso Dermatology Research Center Las Vegas, Nevada EDITOR-IN-CHIEF, AESTHETIC DERMATOLOGY W. Philip Werschler, MD, FAAD, FAACS Assistant Clinical Professor of Medicine/Dermatology University of Washington School of Medicine Seattle, Washington ASSOCIATE EDITOR Seemal R. Desai, MD, FAAD Clinical Assistant Professor of Dermatology University of Texas Southwestern Medical Center Dallas, Texas VICE PRESIDENT/EXECUTIVE EDITOR Kimberly B. Chesky Vice President/Executive Editor, Dermatology Division Matrix Medical Communications ASSOCIATE EDITOR Elizabeth A. Klumpp Vice President/Editorial Director, all divisions Matrix Medical Communications ASSOCIATE EDITOR Angela M. Saba Managing Editor, Bariatric Division Matrix Medical Communications ASSISTANT EDITOR Frank Hosking III Matrix Medical Communications 1595 Paoli Pike • Suite 201 • West Chester, PA 19380 BUSINESS STAFF PRESIDENT Robert L. Dougherty Group Publisher, all divisions Matrix Medical Communications VICE PRESIDENT, PUBLISHER Joseph J. Morris Publisher, Dermatology Division Matrix Medical Communications VICE PRESIDENT Christine C. Franey Business Development, all divisions Matrix Medical Communications ASSOCIATE DIRECTOR OF BUSINESS DEVELOPMENT Christopher Moccia Business Development, all divisions Matrix Medical Communications PARTNER Patrick D. Scullin Matrix Medical Communications Official journal of American Acne & Rosacea Society JCAD is indexed in the following reference sources: PubMed Central, CINAHL, EMBASE, Scopus Cover photo: Reprinted with permission from: Siller G, Rosen R, Freeman M, et al. PEP005 (ingenol mebutate) gel for the topical treatment of superficial basal cell carcinoma: results of a randomized phase IIa trial. Austral J Dermatol. 2010;51:99–105.

Articles in this issue

Links on this page

Archives of this issue

view archives of Journal of Clinical and Aesthetic Dermatology - Ingenol Mebutate Topical Gel 2016